• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sidoti's Micro-Cap Virtual May Conference

    5/9/23 7:15:00 AM ET
    $ATEX
    $AYRO
    $CODA
    $CYTO
    Telecommunications Equipment
    Telecommunications
    Telecommunications Equipment
    Consumer Discretionary
    Get the next $ATEX alert in real time by email

    NEW YORK, NY / ACCESSWIRE / May 9, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day May Micro-cap Conference taking place Wednesday and Thursday, May 10-11, 2023. Presentation schedule is subject to change, please visit www.sidoti.com/events for the most updated version and webinar links. For investor registration and to request 1x1 meetings, please visit https://www.sidoti.com/events/may-micro-cap-virtual-conference.

    Presentation Schedule

    Sidoti & Company, LLC, Monday, May 1, 2023, Press release picture

    *All Times EDT

    Wednesday, May 10th, 2023 (Day 1)

    8:30-9:00

    Coda Octopus Group, Inc. (CODA)

    *****

    Hillstream BioPharma, Inc. (HILS)

    SosTravel.com SpA (SOSAF)

    9:15-9:45

    ReWalk Robotics (RWLK)

    GigaCloud Technology Inc (GCT)

    ZyVersa Therapeutics (ZVSA)

    Netcapital Inc (NCPL)

    10:00-10:30

    Guerrilla RF, Inc. (GUER)

    Bion Environmental Technologies (BNET)

    Lisata Therapeutics (LSTA)

    Acme United Corporation (ACU)

    10:45-11:15

    *****

    Lee Enterprises (LEE)

    NeuroOne Medical Tech (NMTC)

    Innovative Solutions & Support (ISSC)

    11:30-12:00

    Anterix (ATEX)

    SAB Biotherapeutics Inc. (SABS)

    Harvard Bioscience (HBIO)

    LifeMD (LFMD)

    12:15-12:45

    Spectra7 Microsystems (SEV)

    LifeVantage Corporation (LFVN)

    TFF Pharmaceuticals (TFFP)

    AYRO, Inc. (AYRO)

    1:00-1:30

    PCTEL (PCTI)

    *****

    Altamira Therapeutics Ltd. (CYTO)

    Corus Entertainment Inc. (CJR.B)

    1:45-2:15

    *****

    Aterian Inc. (ATER)

    Baudax Bio (BXRX)

    BlackSky Technology Inc. (BKSY)

    2:30-3:00

    *****

    Black Diamond Group (BDI)

    Synlogic Inc (SYBX)

    Innovative Eyewear, Inc. (LUCY)

    3:15-3:45

    Amesite Inc. (AMST)

    ARC Document Solutions (ARC)

    *****

    *****

    4:00-4:30

    Mawson Infrastructure Group (MIGI)

    *****

    Kintara Therapeutics, Inc. (KTRA)

    *****

    1x1s Only

    (10th)

    Hooker Furnishings Corp (HOFT)

    Manitex International (MNTX)

    *****

    *****

    *All Times EDT

    Thursday, May 11th, 2023 (Day 2)

    8:30-9:00

    *****

    Polypid Ltd. (PYPD)

    HydroGraph Clean Power Inc. (HG)

    *****

    9:15-9:45

    Orange Polska (OPL)

    AnPac Bio-Medical Science (ANPC)

    InfuSystem Holdings Inc. (INFU)

    Olympic Steel, Inc. (ZEUS)

    10:00-10:30

    Intellicheck (IDN)

    VersaBank (VBNK)

    *****

    Quadient (QDT)

    10:45-11:15

    CPS Technologies Corp. (CPSH)

    Apogee Enterprises, Inc. (APOG)

    Virpax Pharmaceuticals, Inc. (VRPX)

    AstroNova, Inc (ALOT)

    11:30-12:00

    Quad/Graphics (QUAD)

    Mistras Group, Inc. (MG)

    Genenta Science (GNTA)

    Argentina Lithium & Energy (PNXLF)

    12:15-12:45

    *****

    Heliogen (HLGN)

    Genprex, Inc. (GNPX)

    The Real Brokerage Inc (REAX)

    1:00-1:30

    SOBR Safe Inc (SOBR)

    Powell Industries, Inc. (POWL)

    Humacyte, Inc. (HUMA)

    Townsquare Media Inc (TSQ)

    1:45-2:15

    Inhibikase Therapeutics, Inc. (IKT)

    Smart Sand, Inc. (SND)

    LogicMark (LGMK)

    Exco Technologies (XTC)

    2:30-3:00

    *****

    Sterling Infrastructure, Inc. (STRL)

    Coya Therapeutics, Inc. (COYA)

    *****

    3:15-3:45

    *****

    Carbon Streaming Corp (OFSTF)

    FSD Pharma Inc. (HUGE)

    *****

    4:00-4:30

    *****

    Super League Gaming, Inc (SLGG)

    Cardiol Therapeutics, Inc. (CRDL)

    *****

    1x1s Only

    (11th)

    Beazer Homes USA, Inc. (BZH)

    FGI Industries (FGI)

    Hooker Furnishings Corp (HOFT)

    *****

    About Sidoti & Company, LLC
    For nearly 25 years, Sidoti & Company, LLC (www.sidoti.com) has been a premier provider of independent securities research focused specifically on small and microcap companies and the institutions that invest in their securities, with most of its coverage in the $200 million-$5 billion market cap range. Sidoti's coverage universe comprises upwards of 200 names of which about one-third participate in the firm's rapidly growing Company Sponsored Research ("CSR") program. Sidoti is also a leading provider of corporate access through the eight investor conferences it hosts each year. Our small- and microcap-focused nationwide sales force, which has relationships with approximately 500 institutional clients in North America, enables the firm to provide multiple forums for meaningful interaction for small and microcap issuers and investors specifically interested in companies in the sector.

    SOURCE: Sidoti & Company, LLC



    View source version on accesswire.com:
    https://www.accesswire.com/753555/Sidotis-Micro-Cap-Virtual-May-Conference

    Get the next $ATEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEX
    $AYRO
    $CODA
    $CYTO

    CompanyDatePrice TargetRatingAnalyst
    SAB Biotherapeutics Inc.
    $SABS
    12/19/2025$15.00Buy
    Guggenheim
    Innovative Solutions and Support Inc.
    $ISSC
    12/5/2025$16.00Buy
    Craig Hallum
    Innovative Solutions and Support Inc.
    $ISSC
    11/21/2025$16.50Outperform
    Northland Capital
    SAB Biotherapeutics Inc.
    $SABS
    9/17/2025$7.00Outperform
    Leerink Partners
    LifeMD Inc.
    $LFMD
    6/18/2025$15.00 → $18.00Buy
    BTIG Research
    SAB Biotherapeutics Inc.
    $SABS
    5/14/2025$10.00Buy
    H.C. Wainwright
    NeuroOne Medical Technologies Corporation
    $NMTC
    5/5/2025$1.45Buy
    Ladenburg Thalmann
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: V.P., CFO and Treasurer Millage Timothy R. covered exercise/tax liability with 4,055 shares, decreasing direct ownership by 12% to 30,186 units (SEC Form 4)

    4/A - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/6/26 6:31:21 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form 4 filed by PRESIDENT Sullivan Eddie Joe

    4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)

    2/5/26 4:55:03 PM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by CEO Reich Samuel J

    4 - SAB Biotherapeutics, Inc. (0001833214) (Issuer)

    2/5/26 4:50:05 PM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lee Enterprises Closes Strategic Investment, Welcomes David Hoffmann to Board

    DAVENPORT, Iowa, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE) today announced that it has closed its previously announced $50 million strategic equity private placement. The investment was led by David Hoffmann ("Hoffmann"), with participation from other existing investors in the Company, providing the Company with committed capital and a strengthened financial and governance foundation as it moves into its next phase. The Company received $50 million of gross proceeds at the closing of the transaction, before transaction expenses. Concurrently with the closing of the $50 million investment, an amendment to the Company's existing credit facility became oper

    2/5/26 4:00:00 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    LifeVantage Declares Quarterly Dividend

    SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products w

    2/4/26 4:06:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LifeVantage Announces Planned Retirement of Steve Fife and CEO Succession Plan

    SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, today announced that after nine years at LifeVantage, Steve Fife, President, Chief Executive Officer and a member of the Board of Directors (the "Board"), has decided to retire in April, 2026. Fife will continue in his role as President and Chief Executive Officer during the transition period to ensure business continuity through his retirement date. The Board is conducting an extensive executive search and anticipates announcing the new CEO in the coming months. "To ensure continuity and po

    2/4/26 4:05:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Lang Scott A. bought $25,068 worth of shares (1,160 units at $21.61), increasing direct ownership by 16% to 8,260 units (SEC Form 4)

    4 - Anterix Inc. (0001304492) (Issuer)

    12/19/25 8:16:48 AM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    Director Lewis Darwin bought $5,265 worth of shares (805 units at $6.54), increasing direct ownership by 0.62% to 131,553 units (SEC Form 4)

    4 - Lifevantage Corp (0000849146) (Issuer)

    12/17/25 4:23:51 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Lang Scott A. bought $50,004 worth of shares (2,450 units at $20.41), increasing direct ownership by 53% to 7,100 units (SEC Form 4)

    4 - Anterix Inc. (0001304492) (Issuer)

    12/10/25 4:21:52 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    $ATEX
    $AYRO
    $CODA
    $CYTO
    SEC Filings

    View All

    SEC Form 8-K filed by Netcapital Inc.

    8-K - Netcapital Inc. (0001414767) (Filer)

    2/6/26 4:30:23 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Amendment: SEC Form 8-A12B/A filed by Lee Enterprises Incorporated

    8-A12B/A - LEE ENTERPRISES, Inc (0000058361) (Filer)

    2/5/26 4:42:33 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Lee Enterprises Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LEE ENTERPRISES, Inc (0000058361) (Filer)

    2/5/26 4:17:08 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on SAB BIO with a new price target

    Guggenheim initiated coverage of SAB BIO with a rating of Buy and set a new price target of $15.00

    12/19/25 8:51:08 AM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Craig Hallum initiated coverage on Innovative Aerosystems with a new price target

    Craig Hallum initiated coverage of Innovative Aerosystems with a rating of Buy and set a new price target of $16.00

    12/5/25 8:44:53 AM ET
    $ISSC
    EDP Services
    Technology

    Northland Capital initiated coverage on Innovative Aerosystems with a new price target

    Northland Capital initiated coverage of Innovative Aerosystems with a rating of Outperform and set a new price target of $16.50

    11/21/25 9:18:43 AM ET
    $ISSC
    EDP Services
    Technology

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Leadership Updates

    Live Leadership Updates

    View All

    LifeVantage Appoints Seasoned Technology Executive Mike Edwards as Chief Technology Officer to Drive Digital Innovation

    SALT LAKE CITY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the addition of Mike Edwards as Chief Technology Officer. Edwards brings more than 25 years of experience as an accomplished senior executive specializing in technology leadership and enterprise transformation. "Mike is a strategic leader with a strong track record of translating technological innovation into measurable business impact and we are delighted to have him join the LifeVantage team," said Steve Fife, President and CEO of LifeVantage. "His expertise in eCo

    1/7/26 4:05:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

    David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the appointment of David Zaccardelli, Pharm.D. to its Board of Directors as Chair of the Board and the appointment of Rita Jain, M.D., as an independent director, both effective immediately. "We are excited to welcome Dr. David Zaccardelli and Dr. Rita Jain to our Board of Directors. I, along with the rest of our Board, am confi

    1/7/26 8:00:00 AM ET
    $SABS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Anterix Appoints Ross Spero as Chief Product Officer

    WOODLAND PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Anterix, Inc. (NASDAQ:ATEX) today announced the appointment of Ross Spero as Chief Product Officer. Spero will lead Anterix's product development strategy, product operations and deployment, and the company's Anterix Active Ecosystem (AAE) partnerships and commercialization strategy, as Anterix advances its evolution beyond spectrum to help utilities accelerate time-to-deployment and time-to-value. Supporting seven utilities with a collective footprint equivalent to the fourth-largest wireless network in the United States, Anterix is entering a new era beyond spectrum—strengthening its lab-to-deployment engine, expanding its solutions

    1/7/26 7:30:00 AM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Financials

    Live finance-specific insights

    View All

    LifeVantage Declares Quarterly Dividend

    SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid March 16, 2026 to all stockholders of record at the close of business on March 2, 2026. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products w

    2/4/26 4:06:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

    SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2025. Second Quarter Fiscal 2026 Summary*: Revenue was $48.9 million, a decrease of 27.8% from the prior year period. Revenue was up 2.9% sequentially from the first quarter.Revenue in the Americas decreased 32.6%, and revenue in Asia/Pacific & Europe decreased 2.1%.Net income per diluted share was $0.02, versus $0.19 per diluted share a year ago;Adjusted earnings per diluted share was $0.15, compared

    2/4/26 4:04:00 PM ET
    $LFVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anterix Sets Third Quarter Fiscal 2026 Earnings Conference Call for Thursday, February 12, at 9:00 a.m. ET

    WOODLAND PARK, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Anterix (NASDAQ:ATEX) announced today that it will hold a conference call on Thursday, February 12, 2026, at 9:00 a.m. ET. Anterix senior management, led by President and CEO Scott Lang, will discuss the Company's third quarter fiscal 2026 results. A press release regarding the results will be issued after the close of the market on Wednesday, February 11, 2026.Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended that you join the call at least 10 minutes before the conference call begins. The call is als

    2/3/26 4:30:00 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    $ATEX
    $AYRO
    $CODA
    $CYTO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by GigaCloud Technology Inc

    SC 13D/A - GigaCloud Technology Inc (0001857816) (Subject)

    12/12/24 3:02:53 PM ET
    $GCT
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Anterix Inc.

    SC 13D/A - Anterix Inc. (0001304492) (Subject)

    12/9/24 8:45:15 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications

    Amendment: SEC Form SC 13G/A filed by NeuroOne Medical Technologies Corporation

    SC 13G/A - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Subject)

    11/26/24 8:42:10 AM ET
    $NMTC
    Medical/Dental Instruments
    Health Care